Medications for Cryopyrinassociated Periodic Syndromes

2 results

  • Arcalyst

    (rilonacept)
    Kiniksa Pharmaceuticals (UK), Ltd.
    Usage: ARCALYST (rilonacept) is indicated for treating Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome, as well as for maintaining remission of Deficiency of Interleukin-1 Receptor Antagonist (DIRA) and treating recurrent pericarditis in patients aged 12 and older.

  • Ilaris

    (canakinumab)
    Novartis Pharmaceuticals Corporation
    Usage: ILARIS (canakinumab) is indicated for treating autoinflammatory Periodic Fever Syndromes, including CAPS, TRAPS, HIDS/MKD, and FMF; active Still's Disease in patients 2 years and older; and symptomatic treatment of gout flares in adults when other treatments are unsuitable.